Back to Minnesota

HF4442 • 2026

State rapid start program established; operation of local rapid start programs to treat patients who are HIV-positive provided; prior authorization, cost sharing, and step therapy for antiretroviral therapy and HIV prevention services prohibited; and money appropriated.

State rapid start program established; operation of local rapid start programs to treat patients who are HIV-positive provided; prior authorization, cost sharing, and step therapy for antiretroviral therapy and HIV prevention services prohibited; and money appropriated.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Pérez-Vega, Momanyi-Hiltsley, Hussein, Feist, Xiong
Last action
2026-04-16
Official status
Author added Xiong
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2026-04-16 House

    Author added Xiong

  2. 2026-03-18 House

    Introduction and first reading, referred to Health Finance and Policy

Official Summary Text

State rapid start program established; operation of local rapid start programs to treat patients who are HIV-positive provided; prior authorization, cost sharing, and step therapy for antiretroviral therapy and HIV prevention services prohibited; and money appropriated.

Current Bill Text

Read the full stored bill text
A bill for an act

relating to health; establishing a state rapid start program; providing for the

operation of local rapid start programs to treat patients who are HIV-positive;

prohibiting prior authorization, cost sharing, and step therapy for antiretroviral

therapy and HIV prevention services; authorizing rulemaking; requiring reports;

appropriating money; proposing coding for new law in Minnesota Statutes, chapters

62Q; 145.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.
new text begin
SHORT TITLE.
new text end

new text begin

This act shall be known as the "Rapid Start HIV Treatment Act of 2026."

new text end

Sec. 2.

new text begin

[62Q.1842] PROHIBITION ON PRIOR AUTHORIZATION, USE OF STEP

THERAPY, AND COST SHARING FOR ANTIRETROVIRAL THERAPY AND

HIV PREVENTION SERVICES.

new text end

new text begin

Subdivision 1.

new text end

new text begin

Definitions.

new text end

new text begin

(a) For purposes of this section, the following terms have

the meanings given.

new text end

new text begin

(b) "Antiretroviral therapy" has the meaning given in section 145.9235, subdivision 1.

new text end

new text begin

(c) "HIV prevention services" means ancillary or supportive services that are necessary

to:

new text end

new text begin

(1) ensure that a preexposure prophylaxis drug is prescribed or administered to an

individual who is HIV negative to prevent HIV transmission, provided the person has no

medical contraindications to the use of a preexposure prophylaxis drug; and

new text end

new text begin

(2) monitor an individual described in clause (1) to ensure the individual's safe and

effective ongoing use of a preexposure prophylaxis drug through office visits, laboratory

testing, testing for sexually transmitted infections, medication self-management and

adherence counseling, or any other health service specified as part of comprehensive HIV

prevention drug services by the United States Department of Health and Human Services,

the United States Centers for Disease Control and Prevention, or the United States Preventive

Services Task Force.

new text end

new text begin

(d) "Step therapy protocol" has the meaning given in section 62Q.184, subdivision 1.

new text end

new text begin

Subd. 2.

new text end

new text begin

Prohibition on use of step therapy protocols and prior authorization.

new text end

new text begin

A

health plan that covers antiretroviral therapy must not limit or exclude coverage for

antiretroviral therapy by requiring prior authorization or requiring an enrollee to follow a

step therapy protocol. A health plan that covers HIV prevention services must not limit or

exclude coverage for these services by requiring prior authorization or requiring an enrollee

to follow a step therapy protocol.

new text end

new text begin

Subd. 3.

new text end

new text begin

Cost sharing prohibited.

new text end

new text begin

A health plan must not impose cost-sharing

requirements, including co-pays, deductibles, or coinsurance, for antiretroviral therapy or

HIV prevention services covered by the health plan.

new text end

new text begin

EFFECTIVE DATE.

new text end

new text begin

This section is effective January 1, 2027, and applies to health

plans offered, sold, issued, or renewed on or after that date.

new text end

Sec. 3.

new text begin

[145.9235] RAPID START HIV TREATMENT PROGRAMS.

new text end

new text begin

Subdivision 1.

new text end

new text begin

Definitions.

new text end

new text begin

(a) For purposes of this section, the following terms have

the meanings given, unless the context clearly indicates otherwise.

new text end

new text begin

(b) "1-3-7 framework" means the initiation of antiretroviral therapy ideally within one

day after a patient's diagnosis with HIV or reengagement in care, allowably within three

days after a patient's diagnosis or reengagement, and in all cases within seven business days

after a patient's diagnosis or reengagement.

new text end

new text begin

(c) "318 grantee" means an entity or program, typically a state or local health department,

public health organization, or academic institution, that receives federal funding from the

Centers for Disease Control and Prevention under section 318 of the Public Health Service

Act for sexually transmitted infection and sexually transmitted disease prevention programs.

A 318 grantee may also be a covered entity under the federal 340B Drug Pricing Program

and may purchase prescription drugs at reduced prices.

new text end

new text begin

(d) "AIDS Drug Assistance Program" or "ADAP" means the state program established

under Part B of the Ryan White HIV/AIDS Program to provide medications approved by

the Food and Drug Administration to treat income-eligible people living with HIV.

new text end

new text begin

(e) "Antiretroviral therapy" or "ART" means a therapy approved by the Food and Drug

Administration for the treatment or prevention of HIV, including a preexposure or

postexposure prophylaxis drug.

new text end

new text begin

(f) "Commissioner" means the commissioner of health.

new text end

new text begin

(g) "Presumptive eligibility for the ADAP" or "presumptive ADAP eligibility" means

eligibility determined according to subdivision 4.

new text end

new text begin

(h) "Rapid start" means a standard of medical care that prioritizes the immediate initiation

of ART for the treatment of HIV using the 1-3-7 framework.

new text end

new text begin

Subd. 2.

new text end

new text begin

State rapid start program established.

new text end

new text begin

(a) The commissioner must establish

a state rapid start program at the department to oversee the implementation and administration

of local rapid start programs under this section. The state rapid start program is responsible

for program development, contract management, training, evaluation, annual reporting on

program outcomes, and providing grants to local rapid start programs to cover a portion of

the cost of ART and access to ART, including during periods of presumptive ADAP

eligibility.

new text end

new text begin

(b) Personnel in the state rapid start program must develop and provide training and

ongoing clinical guidance on rapid start to primary care providers and infectious disease

specialists.

new text end

new text begin

(c) The commissioner may adopt rules to implement this section.

new text end

new text begin

Subd. 3.

new text end

new text begin

Local rapid start programs.

new text end

new text begin

(a) The commissioner, through the state rapid

start program, must establish and maintain local rapid start programs at designated HIV

testing and clinical care sites.

new text end

new text begin

(b) A local rapid start program maintained under this section must:

new text end

new text begin

(1) implement a standard of medical care that prioritizes the immediate initiation of

antiretroviral therapy according to the 1-3-7 framework for the treatment of HIV to reduce

HIV levels as quickly as possible. Under the 1-3-7 framework, initiation within one day

after HIV diagnosis or reengagement in care is highly preferred, within three days after

diagnosis or reengagement is considered good practice, and within seven business days

after diagnosis or reengagement is considered sufficient;

new text end

new text begin

(2) provide direct care or care coordination that ensures:

new text end

new text begin

(i) immediate access to extended clinical appointments;

new text end

new text begin

(ii) prescribing or dispensing of ART within the 1-3-7 framework; and

new text end

new text begin

(iii) access to comprehensive support services, including but not limited to health

education, transportation, housing assistance, nutrition, and psychosocial supports;

new text end

new text begin

(3) closely communicate and coordinate with HIV testing programs to facilitate timely

connection to care; and

new text end

new text begin

(4) operate in a nondiscriminatory manner and provide equitable access to services for

all individuals, regardless of race, ethnicity, gender identity, sexual orientation, mode of

exposure to HIV, immigration status, or ability to pay for treatment.

new text end

new text begin

Subd. 4.

new text end

new text begin

Presumptive eligibility for ADAP.

new text end

new text begin

The commissioner of human services must

develop and communicate to local rapid start programs a process to determine a patient's

presumptive eligibility for the ADAP. Under this process, an individual is presumptively

eligible for the ADAP if the individual orally attests to meeting the income and residency

requirements for the ADAP and provides evidence of HIV infection in the form of either

(1) a test result from a reactive HIV test approved by the Food and Drug Administration,

or (2) a clinical diagnosis. A local rapid start program must make a determination on an

individual's presumptive eligibility within one business day after the individual's application.

An individual's period of presumptive eligibility shall last for at least 30 days from the date

of determination and may be extended at the discretion of the local rapid start program.

new text end

new text begin

Subd. 5.

new text end

new text begin

Funding and reimbursement.

new text end

new text begin

Local rapid start programs shall be funded with

state funds, federal funds, and other available funding sources and must use funds in the

following order of priority:

new text end

new text begin

(1) medical assistance, MinnesotaCare, and private insurance coverage;

new text end

new text begin

(2) funding for 318 grantees to support services for uninsured and underinsured

individuals;

new text end

new text begin

(3) resources from the Ryan White HIV/AIDS Program and the ADAP to provide

supplemental coverage; and

new text end

new text begin

(4) grants distributed by the commissioner to cover a portion of the cost of ART and

ensure access to ART without patient cost sharing or delays due to prior authorization,

including during periods of presumptive ADAP eligibility.

new text end

new text begin

Subd. 6.

new text end

new text begin

Data collection and reporting.

new text end

new text begin

Local rapid start programs must collect and

maintain detailed data on program enrollment, ART initiation time frames, demographic

information of patients served by the program, and health outcomes for patients served by

the program. A local rapid start program must at least collect and maintain data on:

new text end

new text begin

(1) the number of patients referred to the program who have evidence of HIV infection

and who are newly diagnosed or reengaged in care;

new text end

new text begin

(2) the number of offers made by program staff to newly diagnosed or reengaged HIV

positive patients to enroll in the program;

new text end

new text begin

(3) the number of newly diagnosed or reengaged HIV-positive patients enrolled in the

program and the number who decline to enroll;

new text end

new text begin

(4) for patients who decline to enroll in the program, their reasons for not enrolling;

new text end

new text begin

(5) for patients enrolled in the program:

new text end

new text begin

(i) the length of time from first evidence of a new HIV-positive diagnosis or reengagement

in care to the initiation of ART; and

new text end

new text begin

(ii) the length of time from the initiation of ART to the achievement of an undetectable

viral load;

new text end

new text begin

(6) the demographics of patients enrolled in the program, including race, ethnicity, age,

sex, gender identity, sexual orientation, modes of exposure to HIV, disability status, primary

or preferred language, housing status, and insurance status; and

new text end

new text begin

(7) the proportion of patients enrolled in the program who belong to demographic

categories identified by local epidemiological data to have challenges engaging with and

being retained in HIV care and who achieve undetectable viral loads within three months

after diagnosis or reengagement.

new text end

new text begin

Subd. 7.

new text end

new text begin

Reports to public and legislature.

new text end

new text begin

(a) By October 1, 2027, and each October

1 thereafter, the commissioner must submit to the legislature and make available to the

public a comprehensive report on the activities of local rapid start programs. Each report

must at least include information on:

new text end

new text begin

(1) the number of local rapid start programs that were in operation in the most recent

reporting period;

new text end

new text begin

(2) the number of patients enrolled in local rapid start programs to date and the proportion

of these patients who initiated antiretroviral therapy one day, three days, or seven days

following an HIV diagnosis or reengagement in care;

new text end

new text begin

(3) challenges identified with program implementation and operations and proposed

responses to challenges; and

new text end

new text begin

(4) rates of rapid start by patients seen by providers who diagnose HIV.

new text end

new text begin

(b) Section 144.05, subdivision 7, does not apply to reports under this subdivision.

new text end

Sec. 4.
new text begin
APPROPRIATION; RAPID START PROGRAMS.
new text end

new text begin

$....... in fiscal year 2027 is appropriated from the general fund to the commissioner of

health for purposes of Minnesota Statutes, section 145.9235.

new text end